Search for: "Price v. HHS" Results 21 - 40 of 121
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Nov 2022, 11:21 pm by Kurt R. Karst
  Pfizer set the price of tafamidis at $225,000 for each one-year course of treatment. [read post]
17 Jul 2022, 9:05 pm by Allison K. Hoffman
The litigants in this case questioned whether this policy was consistent with the Medicare statute, which says HHS may pay based on hospitals’ acquisition cost, if HHS collects survey data on those costs, or, if not, based on average sale prices. [read post]
15 Jun 2022, 11:12 pm by Kurt R. Karst
Circuit, but today, the Supreme Court reversed again and upheld the District Court’s opinion in American Hospital Assn v. [read post]
19 Apr 2022, 5:05 am by David W.S. Lieberman
 See, e.g,, HHS-OIG Advisory Opinion No. 13-03; United States v. [read post]
3 Jan 2022, 6:55 am by DONALD SCARINCI
” If HHS has not collected adequate “hospital acquisition cost data,” it must set a reimbursement rate equal to the “average price for the drug,” which is “calculated and adjusted by [HHS] as necessary for purposes of” the statute. [read post]
27 Dec 2021, 6:55 am by DONALD SCARINCI
” If HHS has not collected adequate “hospital acquisition cost data,” it must set a reimbursement rate equal to the “average price for the drug,” which is “calculated and adjusted by [HHS] as necessary for purposes of” the statute. [read post]
28 Jul 2021, 4:42 pm by Bona Law PC
Healthcare The Order (i) directs the Food and Drug Administration (FDA) to work with states and tribes to safely import prescription drugs from Canada, pursuant to the Medicare Modernization Act of 2003; (ii) directs the Health and Human Services Administration (HHS) to increase support for generic and biosimilar drugs, which can provide low-cost options for patients; (iii) directs HHS to issue a comprehensive plan within 45 days to combat high prescription drug prices and… [read post]